Dr. Dustin Deming: March 20, 2018

***March is National Colon Cancer Awareness Month***

SCREENING INCREASES THE CHANCES OF CATCHING COLORECTAL CANCER EARLY, WHEN IT IS MOST LIKELY TO BE TREATED SUCCESSFULLY

More than 50,000 Americans are expected to die from colon cancer in 2018,2 and 1 in 3 are not getting recommended screenings 

Dr. Dustin Deming

Gastrointestinal Oncologist at the University of Wisconsin Carbone Cancer Center (UWCCC)

Colorectal cancer (CRC) is the third leading cause of cancer deaths of both men and women; however, it may be successfully treated if caught early through screening.1 Screening is a very important way to detect CRC in an early stage, when a person may have no noticeable signs or symptoms.1 In fact, the rates of new CRC cases and deaths for people who are 50 years or older has been decreasing for decades, in part due to an increase in screening.2 Despite this progress, 1 in 3 adults over the age of 50 are not up-to-date with recommended colorectal cancer screening.3

On March 20, Dr. Deming, a colorectal cancer expert, will be available for interview and can speak about CRC screening, trends, signs and symptoms, diagnosis and treatments.

Additional Colorectal Cancer Facts Include:

  • According to the American Cancer Society, an estimated 140,000 new cases of CRC will be diagnosed this year and more than 50,000 people will die from the disease.2
  • Most people with early CRC don’t show any signs or symptoms of the disease, which is why it is recommended to get screened regularly.1
  • Nearly 40% of CRC cases are diagnosed at the local stage, before it has spread to other parts of the body, for which the 5-year survival is 90%.3

 

About Dustin Deming, M.D.

Dr. Dustin Deming is a gastrointestinal oncologist at the University of Wisconsin Carbone Cancer Center (UWCCC) with a subspecialty focus in the treatment of colorectal cancers. His clinical and basic science research focus on the identification of new treatment strategies for cancer subtypes, including precision medicine and immunotherapies. In addition to being a cancer physician and researcher, he is also a colorectal cancer patient, having been diagnosed with colorectal cancer at 31 years old. He is the ECOG-ACRIN Colorectal Cancer Subcommittee Chair, co-director of the UWCCC Precision Medicine Molecular Tumor Board, member of the National Cancer Institute’s Rectal and Anal Cancer Task Force and a member of the National Comprehensive Cancer Network’s Colorectal and Anal Cancer committee.

About Colorectal Cancer

According to the American Cancer Society, the incidence of colorectal cancer has been declining for several decades in older adults, due to changing patterns in risk factors and increased screening.2 Men and women who are at average risk for colorectal cancer should begin screening at the age of 50, and in 2018, approximately 1 in 22 men and 1 in 24 women will be diagnosed with CRC in their lifetime.2,3

For more information:

 www.loveyourcolon.org, https://www.ccalliance.org and http://fightcolorectalcancer.org

Speak Your Mind

*